• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EBI, LLC. ORTHOPAK ASSEMBLY; STIMULATOR, ORTHOPAK, NONIVASIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EBI, LLC. ORTHOPAK ASSEMBLY; STIMULATOR, ORTHOPAK, NONIVASIVE Back to Search Results
Model Number N/A
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Pain (1994); Discomfort (2330)
Date of Event 07/29/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Zimmer biomet (b)(4).Date of event: (b)(6) 2021.Medical product: unknown.Therapy date: unknown.The device will not be returned for analysis; however, an investigation of the reported event is in progress.Once the investigation is complete, a supplemental medwatch 3500a will be submitted.
 
Event or Problem Description
It was reported by the sales rep who states the patient is having some tightness and discomfort while using her orthopak for her hip.Patient stated that she is having some tightness and discomfort while using unit.Patient states pain started same day she received unit states muscles in her leg was tight and pain go into her inner thigh.Patient states pain level is 10.Patient states she did not seek medical treatment and taking percocet¿s and muscles relaxer.She states she will be seeing her doctor tuesday and will call back with update.Advised her to conduct a time test at one-hour increments after her pain subsides.Treat 1 hour per day for the first three days.If she does not experience any pain, she should increase treatment time by 1 hour each day after that.Advised her to call back with any issue during the time test.
 
Additional Manufacturer Narrative
Corrections in b4: date of the report, b5: event description, d3: manufacturer g1: contact office, g6: type of report, h2, h8 and h3.Additional information in d4: udi, h4: device manufacture date, h6: component, investigation type, findings, and conclusions and h10: additional narrative.This follow-up report is being submitted to relay additional and corrected information.The device was not returned to highridge medical for evaluation.The reported event was unable to be confirmed due to limited information received from the customer.The device history record was reviewed, and no discrepancies related to the reported event were found.Root cause was unable to be determined as the necessary information to adequately investigate the reported event was not provided.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Highridge medical will continue to monitor for trend.
 
Event or Problem Description
It was reported by the sales rep who states the patient is having some tightness and discomfort while using her orthopak for her hip.Patient stated that she is having some tightness and discomfort while using unit.Patient states pain started same day she received unit states muscles in her leg was tight and pain go into her inner thigh.Patient states pain level is 10.Patient states she did not seek medical treatment and taking percocet¿s and muscles relaxer.She states she will be seeing her doctor tuesday and will call back with update.Advised her to conduct a time test at one-hour increments after her pain subsides.Treat 1 hour per day for the first three days.If she does not experience any pain, she should increase treatment time by 1 hour each day after that.Advised her to call back with any issue during the time test.No additional patient consequences have been reported.Orthopak was not returned for further evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORTHOPAK ASSEMBLY
Common Device Name
STIMULATOR, ORTHOPAK, NONIVASIVE
Manufacturer (Section D)
EBI, LLC.
1 gatehall dr
suite 303
parsippany NJ 07054
Manufacturer (Section G)
EBI, LLC
1 gatehall dr
suite 303
parsippany NJ 07054
Manufacturer Contact
drashti patel
1 gatehall dr
suite 303
parsippany, NJ 07054
9732999300
MDR Report Key12365651
Report Number0002242816-2021-00151
Device Sequence Number4418120
Product Code LOF
UDI-Device Identifier00812301020232
UDI-Public00812301020232
Combination Product (Y/N)N
Initial Reporter StateAL
Initial Reporter CountryUS
PMA/510(K) Number
P850022
Exemption Number5645646
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 06/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Other
Device Model NumberN/A
Device Catalogue Number1067718
Device Lot NumberN/A
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/29/2021
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date08/25/2021
Supplement Report FDA Received Date06/05/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/29/2021
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
N/A
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H10 NARRATIVE; SEE H10 NARRATIVE
Outcome Attributed to Adverse Event Required Intervention;
Patient SexPrefer Not To Disclose
Patient EthnicityNon Hispanic
-
-